The secreted polypeptide, encoded by this gene, binds and
inactivates members of the transforming growth factor-beta
(TGF-beta) superfamily signaling proteins, such as bone
morphogenetic protein-4 (BMP4). By diffusing through extracellular
matrices more efficiently than members of the TGF-beta superfamily,
this protein may have a principal role in creating morphogenic
gradients. The protein appears to have pleiotropic effect, both
early in development as well as in later stages. It was originally
isolated from Xenopus based on its ability to restore normal
dorsal-ventral body axis in embryos that had been artificially
ventralized by UV treatment. The results of the mouse knockout of
the ortholog suggest that it is involved in numerous developmental
processes, such as neural tube fusion and joint formation.
Recently, several dominant human NOG mutations in unrelated
families with proximal symphalangism (SYM1) and multiple synostoses
syndrome (SYNS1) were identified; both SYM1 and SYNS1 have multiple
joint fusion as their principal feature, and map to the same region
(17q22) as this gene. All of these mutations altered evolutionarily
conserved amino acid residues. The amino acid sequence of this
human gene is highly homologous to that of Xenopus, rat and mouse.1) Rudnik-Schoneborn, S., et al. Am. J. Med. Genet.152A (6), 1540-1544 (2010) :
Immunogen
This NOG antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 84-111 amino acids from the Central region of human NOG.
Western blot analysis in mouse liver tissue lysates (35ug/lane).
Application
Western Blot at 1:1000 dilution + HepG2 whole cell lysate Lysates/proteins at 20 ug per lane.
Application Notes
For WB starting dilution is: 1:1000:
Additional Information
Form
Liquid
Storage Instructions
Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.